Michaela Liedtke
Stanford Health Care · 342 works · 14,382 citations · h-index 57
Top works
- Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
- Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
- Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy
- Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
- Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population
- Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
- A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403
- Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis
- Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
- A site-directed mutagenesis study to identify amino acid residues involved in the catalytic function of the restriction endonuclease EcoRV
- NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018
- Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia
- Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long‐term survival follow‐up from the randomized, phase 3 INO‐VATE study
- First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction
- Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
- AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin
- NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016
- The Transcription Factor Encyclopedia
- Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
- Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis